Dominating the Negative: How DNMT3A Mutations Contribute to AML Pathogenesis

Cell Stem Cell - United States
doi 10.1016/j.stem.2016.12.008
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

The Combination of NPM1, DNMT3A and IDH1/2 Mutations Leads to Inferior Overall Survival in AML

American Journal of Hematology
Hematology
2019English

DNMT3A Mutations in Myeloproliferative Neoplasms

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

Prognostic Relevance of DNMT3A R882 Mutations in AML Patients Undergoing Non-Myeloablative Conditioning Hematopoietic Stem Cell Transplantation

Bone Marrow Transplantation
TransplantationHematology
2018English

The R882H DNMT3A Mutation Associated With AML Dominantly Inhibits Wild-Type DNMT3A by Blocking Its Ability to Form Active Tetramers

Cancer Cell
Cancer ResearchOncologyCell Biology
2014English

How Can Cognitive Science Contribute to Sport? How Can Sport Contribute to Neuroscience?

Baltic Journal of Health and Physical Activity
2016English

Low Frequency of DNMT3A Mutations in Pediatric AML, and the Identification of the OCI-AML3 Cell Line as an in Vitro Model

Leukemia
Cancer ResearchOncologyAnesthesiologyPain MedicineHematology
2011English

Bone Marrow Microenvironment in the Pathogenesis of AML

2011English

How Psychiatrists Can Contribute to the Public Health

Advances in Psychiatric Treatment
1997English

How to Contribute Research Results to Internet Standardization

Computer Communication Review
Computer NetworksSoftwareCommunications
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy